177 related articles for article (PubMed ID: 22580374)
1. Region-specific elevation of D₁ receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit/hyperactivity disorder.
Ohno Y; Okano M; Masui A; Imaki J; Egawa M; Yoshihara C; Tatara A; Mizuguchi Y; Sasa M; Shimizu S
Neuropharmacology; 2012 Sep; 63(4):547-54. PubMed ID: 22580374
[TBL] [Abstract][Full Text] [Related]
2. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
Howells FM; Russell VA
Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
[TBL] [Abstract][Full Text] [Related]
3. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
Mc Fie S; Sterley TL; Howells FM; Russell VA
Brain Res; 2012 Jul; 1467():91-103. PubMed ID: 22658977
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder.
Jensen V; Rinholm JE; Johansen TJ; Medin T; Storm-Mathisen J; Sagvolden T; Hvalby O; Bergersen LH
Neuroscience; 2009 Jan; 158(1):353-64. PubMed ID: 18571865
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats.
Diaz Heijtz R; Castellanos FX
Behav Brain Funct; 2006 May; 2():18. PubMed ID: 16729883
[TBL] [Abstract][Full Text] [Related]
8. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
Brain Res; 1995 Apr; 676(2):343-51. PubMed ID: 7614004
[TBL] [Abstract][Full Text] [Related]
9. Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder.
de Villiers AS; Russell VA; Sagvolden T; Searson A; Jaffer A; Taljaard JJ
Neurochem Res; 1995 Apr; 20(4):427-33. PubMed ID: 7651580
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
[TBL] [Abstract][Full Text] [Related]
11. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
[TBL] [Abstract][Full Text] [Related]
12. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
Ueno K; Togashi H; Yoshioka M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
[TBL] [Abstract][Full Text] [Related]
13. Renewal of an extinguished instrumental response: neural correlates and the role of D1 dopamine receptors.
Hamlin AS; Blatchford KE; McNally GP
Neuroscience; 2006 Nov; 143(1):25-38. PubMed ID: 16949214
[TBL] [Abstract][Full Text] [Related]
14. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro.
Yoon SY; dela Peña I; Kim SM; Woo TS; Shin CY; Son KH; Park H; Lee YS; Ryu JH; Jin M; Kim KM; Cheong JH
Arch Pharm Res; 2013 Jan; 36(1):134-40. PubMed ID: 23371806
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of neurotransmitter receptor and regulatory genes in the prefrontal cortex of spontaneously hypertensive rats: relevance to neuropsychiatric disorders.
Santoro ML; Santos CM; Ota VK; Gadelha A; Stilhano RS; Diana MC; Silva PN; Spíndola LM; Melaragno MI; Bressan RA; Han SW; Abílio VC; Belangero SI
Psychiatry Res; 2014 Nov; 219(3):674-9. PubMed ID: 25041985
[TBL] [Abstract][Full Text] [Related]
16. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
[TBL] [Abstract][Full Text] [Related]
17. Quantitative regional cerebral blood flow MRI of animal model of attention-deficit/hyperactivity disorder.
Danker JF; Duong TQ
Brain Res; 2007 May; 1150():217-24. PubMed ID: 17391651
[TBL] [Abstract][Full Text] [Related]
18. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder.
Barth V; Need AB; Tzavara ET; Giros B; Overshiner C; Gleason SD; Wade M; Johansson AM; Perry K; Nomikos GG; Witkin JM
J Pharmacol Exp Ther; 2013 Feb; 344(2):501-10. PubMed ID: 23197772
[TBL] [Abstract][Full Text] [Related]
19. Characterization of regional cerebral blood flow and expression of angiogenic growth factors in the frontal cortex of juvenile male SHRSP and SHR.
Jesmin S; Togashi H; Mowa CN; Ueno K; Yamaguchi T; Shibayama A; Miyauchi T; Sakuma I; Yoshioka M
Brain Res; 2004 Dec; 1030(2):172-82. PubMed ID: 15571667
[TBL] [Abstract][Full Text] [Related]
20. Effects of dopamine D1 receptor blockade in the prelimbic prefrontal cortex or lateral dorsal striatum on frontostriatal function in Wistar and Spontaneously Hypertensive Rats.
Gauthier JM; Tassin DH; Dwoskin LP; Kantak KM
Behav Brain Res; 2014 Jul; 268():229-38. PubMed ID: 24755309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
